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ALTHOUGH Maisin and Picard (1924) induced cancer ofthe bladder by implant-
ing pellets containing tar into the bladders ofrats, Bonser, Clayson and Jull (1951)
developed the technique of bladder implantation in mice, which as modified by
Allen, Boyland, Dukes, Horning and Watson (1957) has been widely used. The
method can be employed to indicate whether a substance is a direct carcinogen
or not, because there is less possibility of metabolic change occurring than with
other routes of administration. A few of the results obtained by the technique in
this laboratory since the publication of Allen et al. (1957) have been published
(Bonser, Boyland, Busby, Clayson, Grover and Jull, 1963), but further results are
presented in this paper.
Onie of the difficulties of the method is the choice of a suitable medium with
which to mix the substances to be tested. Most apparently inert materials induce
tumours in a proportion ofmice and even the most active carcinogens do not induce
cancer in all the mice treated. For this reason a few substances which would be
expected to be biologically inert have been tried.
METHODS AND MATERIALS
The technique used was the same as that described by Allen et al. (1957). With
practice it is possible to expose the bladder and insert the pellet through a small
incision in the skin. The incision may be so small that it can be closed with a single
stitch. The probability that the incidence of tumours was due to chance was
calculated by the x2 test. Stock mice bred in the Chester Beatty Research Insti-
tute were used.
Cholesterol (Roche Products), and stearic acid (B.D.H.) were recrystallised
from ethanol. Hexadeconal (cetyl alcohol) and octadecanol were purchased from
British Drug Houses Ltd.
RESULTS AND DISCUSSION
Turmour Induction with " Inert " Vehicles
The incidence of tumours with inert substances some of which might be used
in place of paraffin wax or cholesterol are given in Table I. Magnesium stearate
gave a low incidence of tumours but it has the disadvantage that in the presence
of chelating agents (e.g. ortho aminophenols and 8-hydroxyquinoline) the magnes-
ium forms chelates. If such agents are being tested they would therefore be
present as chelates.
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TABLE L.-Incidence of bladder tumours in mice implanted with inert materials
Numbers of mice
With Tumour
Surviving adenoma or With incidence
Substance Reference 30 weeks papilloma carcinoma %
Cholesterol . Bryan et al., 1963 87 ? 7 . 8
Cholesterol . Allen et al., 1957 21 0 1 5
Cholesterol . Bonser et al., 1958 . 55 ? 5 9
Cholesterol This paper . 77 4 5 12
Stearic acid . Bonser et al., 1963 62 5 3 13
Paraffin wax Bonser et al., 1958 56 ? 2 4
Paraffin wax . Bonser et al., 1963 82 1 1 2
Paraffin wax . Ball et al., 1964 . 62 22 32
Smooth glass ,, 67 3 4
Roughened glass . ., 63 18 29
Magnesium stearate . This paper . 41 1 1 5
n-Hexadecanol . This paper . 69 2 6 12
(cetyl alcohol)
n-Octadecanol . This paper . 50 7 6 . 26
Naphthalene . This paper . 23 0 1 4
Two saturated alcohols were tested and found to have no advantages over
cholesterol; n-hexadecanol gave the same incidence of tumours as cholesterol (12
per cent) and n-octadecanol an even higher incidence (26 per cent). Naphthalene
is a substancewhichappearedto have therequisiteproperties andiseasily obtained
in a pure condition. Although it gave a low incidence oftumours (4 per cent), the
pellets rapidly disintegrated in the bladder. Such quick disintegration shortens
the time during which the bladder is exposed to the substance under test.
Although Bonser, Clayson and Jull (1958) and Bonser, Boyland, Busby, Clay-
son, Grover and Jull (1963) obtained less than 5 per cent of tumours with paraffin
wax, Ball, Field, Roe and Walters (1964) found a high incidence (32 per cent) of
carcinomata in mice implanted with the same preparation of paraffin wax, and
showed that the implantation of roughened glass beads induced a much higher
incidence of tumours than did smooth glass beads.
The results ofthe present experiments and ofother investigations show that all
inert substances which have been tried induce a certain number of tumours. In
the present work cholesterol, stearic acid and magnesium stearate have been used
as vehicles for the tests. Both cholesterol and paraffin wax appear to be suitable
vehicles, but cholesterol is a single chemical substance while paraffin wax is a
mixture of hydrocarbons of variable composition.
Pellets made of stearic acid remain intact in the mouse bladder for only a few
weeks whereas cholesterol pellets remain in the bladder for at least a year. This
means that substances are released morerapidlyfrom stearic acid than from choles-
terol or paraffin wax. Ifthe substance under test has a threshold concentration for
carcinogenic action then it might be released too slowly from cholesterol to give an
effective concentration. Thus Allen et al. (1957) showed that 3-hydroxyanthranilic
acid, which was released veryslowlyfromparaffin wax, wasnot carcinogenicin wax
pellets but was when cholesterol pellets were used. On the other hand slower
release would probably increase the carcinogenic action as the activity of other
carcinogens (e.g. aminostilbenes) has been shown to be proportional to CTN, where
C is the concentration of the carcinogen and T the time of exposure and N iS a
constant greater than 2 (Duckrey and Schmahl, 1962). Bryan, Brown and PriceI-MPLANTATION OF MATERIALS INTO MOUSE BLADDER
(1963) have measured the in vivo rate of release of a variety of compounds from
cholesterol pellets and have found that the time for half the compound to diffuse
from the pellet (T 2) varied between 0 7 and 107 days. There was no apparent
correlation between the rate of release and the carcinogenic activity of the com-
pounds used.
Because of the unknown relationships of concentration and time to possible
carcinogenic activity it seems advisable to test new substances in inert media with
different rates of release. In tests by the method of bladder implantation now
being carried out, however, only pellets made of cholesterol are used because
another substance with suitable properties for a vehicle is not available.
Substances implanted in cholesterol pellets
Many substances have been tested by implantationi in pellets of cholesterol
since the results published by Allen et al. (1957). These, summarised in Table II,
are for the most part inconclusive because too few animals were used in each group.
They show that unless a substance produces a high incidence oftumours, groups of
fewer than 30 mice are insufficient to give a conclusive result.
Six substances listed in Table II, which were tested on sufficiently large groups
of mice to indicate that they are inactive are 2-hydroxylaminobenzoic acid,
2-hydroxylamino-1,3,5-trimethylbenzene, 4-nitronydrazobeizene, 2-amino-i-naph-
thyl phosphate, 8-hydroxyquinoline in mice treated with 1 -> 4-saccharolactone,
1-tryptophan and quinine sulphate.
Substances in Table II in which the incidence cf tumours was sufficiently high
to indicate carcinogenic activity include 4-aminoantipyrene (4-amino-phenazone),
4-acetamido-2'-hydroxy-6'-methylazobenzene (Celliton Yellow), 4-dimethylamino-
3-hydroxyazobenzene, 2-acetamidonaphthalene, bis-(2-amino-1-naphthyl) phos-
phate, 3-methoxyanthranilic acid, hydroquinone, and 2-fluorenylhydroxylamine.
Compounds which gave positive results on few mice and which need further
investigations are 8-hydroxyquinoline glucuronide in mice treated with citric acid
in drinking water and 8-methoxyquinoline.
Substances tested in pellets of stearic acid
Of the substances tested in pellets of stearic acid only 1-naphthylhydroxyl-
amine and 2-naphthylhydroxylamine (Table III) gave a higher incidence of
tumours than stearic acid alone. Of the other substances investigated in this
medium, 2-hydroxylaminobenzoic acid was remarkable in that it produced a high
(15 per cent) incidence of hyperplasia.
Two compounds, bis-(2-amino-1-naphthyl) phosphate and 2-fluorenylhydroxyl-
amine, which were found to be negative when stearic acid pellets were used, gave
significantly positive results when cholesterol was the vehicle (Table II). Bis-
(2-amino-1-naphthyl) phosphate has also given positive results when implanted in
paraffin wax pellets (Bonser et al. 1963). The negative result with 3-hydroxy-
anthranilic acid contrasts with the positive results for this substance in cholesterol
pellets obtained by Allen et al. (1957) and Bryan et al. (1963).
The data indicate that the test using pellets ofstearic acid is less sensitive than
when cholesterol is used and there appears to be no advantage in using stearic acid
as a vehicle.
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TABLE II.-Lesions in mice following implantation of cholesterol pellets containing
different compounds into the bladder
Compound
Controls:
Cholesterol pellets only
with injections of saccharin
with injections of urethane
Aniline derivatives:
2-Hydroxylamino benzoic acid
4-Aminoantipyrin (4-aminophenazone)
2-Aminoacetophenone
4-Hydroxylaminomethylbenzene
2-Hydroxylamino-1,3,5-trimethylbenzene
Azo derivatives:
4-Acetamido-2'-hydroxy-6'-methylbenzene (Cel-
liton Yellow)
4-Dimethylamino-2'-hydroxyazobenzene
4-Dimethylamino-3-hydroxyazobenzene
4-Dirnethylamino-4'-hydroxyazobenzene
4-Nitrohydrazobenzene
2-Naphthylamine derivatives:
2-Acetamidonaphthalene
2-Acetamido-6-naphthyl glucosiduronic acid
2-Amino-l-naphthyl sulphate (potassium salt)
2-Amino-3-naphthol
2-Amino-6-naphthyl sulphate (potassium salt)
2-Acetamido-l-naphthyl glucosiduronic acid
2-Amino-1-naphthyl sulphate-N-glucosiduronic
acid
2-Amino-l-naphthyl-glucosiduronic acid in mice
treated with 3% saccharolactone in drinking
water
2-Amino-1-naphthyl phosphate (mono sodium
salt)
bis-(2-Ainino-l-naphthyl) sodium phosphate
1-Dimethylamino-2-naphthol
2-Naphthyl-bis-(2-chloroethyl)amine
N-Acetyl-2-naphthylhydroxylamine*
Arylhydroxylamine derivatives:
N-Acetyl-4-biphenylylhydroxylamine*
2-Fluorenylhydroxylamine
Chelating agents and related derivatives:
Dipyridyl
8-Hydroxyquinoline glucosiduronic acid
8-Hydroxyquinoline glucosiduronic acid in mice
treated with citric acid in drinking water
8-Hydroxyquinoline glucosiduronic acid in mice
treated with 1 -+ 4-saccharolactone in drinking
water (3 per cent)
8-Hydroxyquinoline copper complex.
8-Hydroxyquinoline ferric iron complex
8-Methoxyquinoline
Tryptophan derivatives:
2-Aminophenoxaz-3-one-1: 9-dicarboxylic acid
3-Amino-4: 5-diacetylphenoxazone
5-Hydroxyanthranilic acid
3-Methoxyanthranilic acid
4-Methyl-3-hydroxyanthranilic acid
Methyl-3-hydroxyanthranilate
I-Tryptophan
Xanthurenic acid
Mice with
Numbers of mice carcinoma,
--- - - adenoma or
With papilloma
Surviving adenoma or With ,
25 weeks papilloma carcinoma % P
77
22
23
76t
18
16
15t
60t
23
20
17
24
58t
75t
18
23
11
17
21
26
26
32
55t
14
15
59t
73t
54t
24
25
11
32
23
12
12
20
24
23
29
18
19
40
17
4
1
0
5
1
2
2
2
1
1
3
0
8
9
3
1
0
0
1
1
1
5
2
1
1
5
1
1
7
6
1
3
2
3
9
0
2
0
2
].
0
3
2
4
1
2
2
0
5
1
0
3
4
0
0
0
4
1
0
2
1
0
2
2
4
12
1
1
1
1
10
2
3
1
1
3
0
4
1
3
4
7
1
4
6
1
12
14
4 -
8 -
33 0 02
18 0-48
20 0 45
15
33 0.03
10
36 0 02
9
19 0-26
23 0 05
16
14
0 -
12
10
4
16 0-5
10
29 0 01
14
20 0 44
5
* 1 -
28 0-02
16
12
37 0 03
10
14
0
32 0*05
25 0-18
16
18 0.5
32 0 02
12
22 0 4
20 0-32
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TABLE II-contd.
Compound
Tobacco constituents:
Aesculetin
Aesculin
Caffeic acid
Catechol
Chlorogenic acid
Guaiacol
Hydroquinone
Quercetin
Rutin
Scopoletin
Tobacco tar
Umbelliferone
Miscellaneous:
Hexanitrodiphenylamine
6-Hydroperoxy-4-cholestene-3-one
Phenylmercuric acetate
Quinine sulphate
Salicylic acid
Trypan blue .
Mice with
Numbers of mice carcinoma,
-lk- ~ ---"I adenoma or
With papilloma
Surviving adenoma or With
25 weeks papilloma carcinoma % P
15
22
16
19
19
14
19
18
17
23
11
17
23
23
13
43
17
16
2
0
1
1
0
0
0
0
1
3
1
1
2
1
2
2
0
0
2 . 27 0-17
2 . 10
1 12
3 . 20 0 4
0 0
0 . 0
6 32 0 03
4 22 0 33
0 . 6 -
0 . 14
0 9
2 . 18 0- 5
0 . 9 -
5 . 27 0-09
2 . 32 0 07
4 . 14 -
3 . 18 0- 5
4 . 25 0-23
* C-strain mice.
t Surviving 40 weeks.
TABLE III.-Lesions in micefollowing implantation ofstearic acidpellets containing
different compounds into the bladder
Numbers of mice
- Mice with adenoma
With carcinoma orpapilloma
Surviving adenoma or With ,_______
Compound 40 weeks papilloma carcinoma % P
Stearic acid only* 62 5 3 . 14
Phenylhydroxylamine 52 3 5 . 15
2-Naphthylamine* . 74 0 0 0
l-Naphthylhydroxylamine* . 26 3 5 . 31 0 048
2-Naphthylhydroxylamine* . 66 14 22 56 <0.001
N-Acetyl-2-naphthylhydroxylamine 81 0 0 . 0
Bi8-(2-Amino-l-naphthyl) sodium 49 0 0 0
phosphate
3-Hydroxyanthranilic acid . . 52 1 1 4
2-Hydroxylaminobenzoic acid . . 60 3 7 17
4-Biphenylylhydroxylamine . . . 55 1 6 . 13
N-Acetyl-4-biphenylylhydroxylamine . 31 0 0 . 0
2-Fluorenylhydroxylamine . . . 62 2 2 . 6
N-Acetyl-2-fluorenylhydroxylamine . 74 0 0 0
C-Methylanthranil . . . . 55 0 0 . 0
* Results also reported in Bonser et al. (1963).
Substances tested in pellets ofmagnesium stearate
In experiments using magnesium stearate as a vehicle (Table IV), a significant
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results obtained with cholesterol pellets (Clayson, Jull and Bonser, 1958). Although
pellets containing indoxyl sulphate, hippuric acid or 3-hydroxyanthranilic acid
produced more tumours than magnesium stearate alone, the differences were not
statistically significant.
TABLE IV.-Lesions in mice following implantation of magnesium stearate pellets
containing different compounds into the bladder
Numbers of mice
--"Mice with adenoma
With carcinoma orpapilloma
Surviving adenoma or With
Compound 40 weeks papilloma carcinoma b p
Magnesium stearate only 41 1 1 5
Indoxyl sulphate . 27 1 4 19 0 07
Hippuric acid 42 2 5 . 17 0 09
1-Methoxy-2-naphthylamine . 27 2 5 26 0 012
3-Hydroxyanthranilic acid . 27 2 3 . 19 0 07
GENERAL DISCUSSION
The results of the experiments reported show some of the difficulties and
limitations of the method of bladder implantation. They indicate that cholesterol
is a suitable vehicle and that at least 40 animals should be used in each group unless
the compound is a potent carcinogen.
The data throw some light on the mechanism of action of aromatic amines.
They confirm the findings of Bonser et al. (1963) and of Bryan et al. (1963) that
some arylhydroxylamines, particularly 2-naphthylhydroxylamine, are local or
direct carcinogens. The carcinogenic actions of 2-acetamidofluorene and of
2-naphthylamine would appear to be effected through the metabolic conversion to
N-acetyl-2-fluorenylhydroxylamine and 2-naphthylhydroxylamine respectively.
On the other hand the possibility that ortho aminophenols are the active
proximate carcinogens cannot be excluded. Thus two possible urinary precursors
of 2-amino-1-naphthol have been found to be carcinogenic by the technique of
bladder implantation; both these esters-2-amino-1-naphthyl-glucosiduronic acid
(Allen et al., 1957) and bis-(2-amino-1-naphthyl)phosphate (Bonser et al., 1963)-
might be hydrolysed to give 2-amino-1-naphthol in the bladder. These positive
results with precursors of 2-amino-1-naphthol are possibly of greater significance
than the positive results ofBonser, Clavson and Jull (1958) and the negative results
ofAllen et al. (1957) and Bryan et al. (1963) with 2-amino-1-naphthol itselfbecause
2-amino-1-naphthol might be released into urine by enzymic hydrolysis. 2-Amino-
1-naphthol itself, however, is such an unstable substance that very little may be
released unchanged from pellets in the bladder, and a number of oxidation and
condensation products of unknown structure may also be formed.
The other carcinogenic ortho aminophenols are the tryptophan metabolites
3-hydroxyanthranilic acid and 3-hydroxykynurenine which Allen et al. (1957) and
Bryan et al. (1963) have found to be carcinogenic to the mouse bladder. The activity
of 3-methoxyanthranilic acid is in agreement with the positive results obtained
with 3-hydroxyanthranilic acid and with 1-methoxy-2-naphthylamine by Clayson,
Jull and Bonser (1958).
The carcinogenic action of aromatic amines on the bladder might therefore be
due, at least in some cases, to the proximate activity ofarylhvdroxylamines andlorIMPLANTATION OF MATERIALS INTO MOUSE BLADDER 581
ortho aminophenols. An enzyme which catalyses the rearrangement of some N-
acetylarylhydroxylamines to ortho acetamidophenols has been found in rat liver
(Booth and Boyland, 1964).
Because the method of bladder implantation allows substances to be tested
which have a direct action, it seemed of value to test constituents of cigarette
smoke which might be carcinogenic. Of the tobacco constituents tested only
hydroquinone gave a significant yield oftumours. This substance could be a contri-
butory cause of cancer in cigarette smokers.
SUMMARY
1. Magnesium stearate, n-hexadecanol, n-octadecanol and naphthalene have
been tested for their suitability as a base for pellets implanted into the bladder of
mice, but were not found to have any advantages over cholesterol.
2. Compounds which have been tested for carcinogenicity by bladder implanta-
tion in cholesterol pellets and which gave positive results include 4-aminoantipy-
rene, 4-acetamido-2'-hydroxy-6'-methylazobenzene (Celliton Yellow), 4-dimethyl-
amino-3-hydroxyazobenzene, 2-acetamidonaphthalene, bi8-(2-amino--1-naphthyl)
phosphate, 3-methoxyanthranilic acid, hydroquinone and 2-fluorenylhydroxyl-
amine.
3. 1-Naphthylhydroxylamine and 2-naphthylhydroxylamine gave positive
results when tested in stearic acid pellets.
4. 1-Methoxy-2-naphthylamine produced tumours when implanted in pellets
of magnesium stearate.
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